Seger Surgical Solutions announced the successful completion of three first-in-human cases in a clinical trial for its proprietary SEGER IDEA laparoscopic bowel closure device.
The procedures, conducted at Zacamil Hospital in El Salvador, represent a milestone in the company's mission to standardize 100% Intracorporeal Anastomosis ("IA"),a technique that keeps the entire bowel closure procedure inside the body.
The SEGER IDEA device enables surgeons to align, close, and staple the common enterotomy quickly and securely entirely inside the body, eliminating the need for complex hand-sewn suturing or the traditional "extracorporeal" method, which requires larger incisions and lifting the bowel outside the abdominal cavity. The El Salvador trial was designed to demonstrate the safety and efficacy of this approach.
Key Clinical Highlights
- Three Successful Cases: All three procedures were completed with ease, achieving 100% intracorporeal results.
- Reduced Procedure Time: Bowel closures were performed in under 2 minutes, compared to the typical 15–20 minutes required for manual laparoscopic suturing.
- Enhanced Patient Recovery: Smaller incisions and reduced tissue handling aim to lower postoperative pain and risk of incisional hernias.
